Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
Increasing evidence has proved that microbiota is not only the target of small molecule drugs but also an underexplored resource for developing small molecule drugs. Meanwhile, microbiota as a critical modulator of the immune system impacts the efficacy and toxicity of cancer immunotherapy. Harnessi...
Saved in:
Main Authors: | Peixin Du (Author), Jing Jing (Author), Xiujing He (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?
by: Shanshan Zhang, et al.
Published: (2024) -
Small-molecule agents for cancer immunotherapy
by: Fang Wang, et al.
Published: (2024) -
Small molecule drug discovery targeting the JAK-STAT pathway
by: You Lv, et al.
Published: (2024) -
Immunogenic cell death‐inducing small molecule inhibitors: Potential for immunotherapy of cancer
by: Zong Sheng Guo, et al.
Published: (2022) -
Computational Discovery of Marine Molecules of the Cyclopeptide Family with Therapeutic Potential
by: Norma Flores-Holguín, et al.
Published: (2023)